vimarsana.com

Page 41 - யேல் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C difficile Infection

Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH™ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) over placebo. RBX2660 is an investigational, potential first-in-class microbiota-based live biotherapeutic

Ferring Pharmaceuticals: Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C difficile Infection

Ferring Pharmaceuticals: Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection (DDW) RBX2660 is the first microbiota-based live biotherapeutic to demonstrate efficacy as early as first recurrence of Clostridioides difficile (C. difficile) infection RBX2660 Phase 3 data add to the world s largest and most robust clinical program ever conducted in the field of microbiome-based therapeutics Findings build on previous RBX2660 clinical trials showing repeated efficacy and consistent safety, including two trials with two years of safety follow-up Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented results from the pivotal Phase 3 PUNCH CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of

Hypertension Risk From Ultra-Processed Food Consumption Impacted by Race

Read Time: Black adults in the U.S. who consumed significant amounts of ultra-processed foods were at 55% increased risk for high blood pressure compared to white adults who ate a similar amount of ultra-processed foods, according to according to preliminary research to be presented at the American Heart Association’s Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2021. The meeting is virtual, May 20-21 and offers the latest science on population-based health and wellness and implications for lifestyle. Ultra-processed foods (UPF) are ready-to-eat formulations of industrially formulated products, typically containing added flavors, colors, and other cosmetic additives, that have been extracted or refined from whole foods, and are typically high in salt, added sugar, and fat. These food products are inexpensive, heavily marketed, and are readily available with a long shelf life.

Seniors enrolled in both Medicare and Medicaid can experience worse outcomes after ICU hospitalization

Seniors enrolled in both Medicare and Medicaid can experience worse outcomes after ICU hospitalization Seniors who are enrolled in both Medicare and Medicaid are at risk for experiencing greater worsening of functional status following ICU hospitalization, according to research presented at the ATS 2021 International Conference. Snigdha Jain, MD, postdoctoral fellow, Yale University School of Medicine, and colleagues sought to examine the association between socioeconomic disadvantage (indicated by dual eligibility for both Medicare and Medicaid), and functional decline in seniors following ICU hospitalization. They found that seniors eligible for Medicaid had 60 percent more disabilities compared to those who did not have Medicaid. After adjusting for variables such as age, gender, education and living alone, Dual Medicare-Medicaid status was still associated with a 30 percent increase in the number of post-ICU disabilities compared with those who did not have Medicaid.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.